VIDEO: EMPULSE results ‘important’ for HF practitioners
Click Here to Manage Email Alerts
In this video, Nancy K. Sweitzer, MD, PhD, discussed results from the EMPULSE trial presented at this year’s American Heart Association Scientific Sessions.
Sweitzer is director of the University of Arizona Sarver Heart Center and professor of medicine and chief of the division of cardiology in the University of Arizona College of Medicine, Tucson.
“I thought the EMPULSE trial was a really important trial for practitioners in the heart failure space,” she said, adding that Adriaan A. Voors, MD, cardiologist at University Medical Center Groningen in the Netherlands, said the trial “fills a missing puzzle piece” in the treatment of patients with acute decompensated HF.
“The trial clearly showed that initiation of empagliflozin in stable patients in the hospital was very safe — without any signals for adverse outcomes — and, in fact, fewer events in the treatment arm than in the placebo arm in that trial,” Sweitzer said.
Collapse
Read more about
Click Here to Manage Email Alerts